CJC-1295 (DAC)
DAC:GRF$109
$21.80 per mg
Size: 5mg
In stock
For Research Use Only. Not for human or veterinary use. Product strictly for laboratory research by qualified individuals. All sales are subject to our Terms & Conditions.
Prices are shown and charged in Canadian dollars (CAD).
Not from Canada? Your bank or payment provider will handle the exact exchange to your local currency automatically. Our currency switcher provides real-time USD estimates for reference only.
TrustLoop™
Partnership
We test, you test,
we reward.
Zero Risk
Protocol™
Purity guaranteed or your
money back. Full stop.
Complete Chain
of Custody
No dropshipping.
Full inventory control.
BATCH MATCHED
COAs
Every batch.
Every time.
cGMP & ISO 5
Benchmarks
Built for labs.
Grounded in protocol.
TrustLoop™
Partnership
We test, you test, we reward.
Zero Risk
Protocol™
Purity guaranteed or your money back.
Complete Chain
of Custody
No dropshipping. Full inventory control.
BATCH MATCHED
COAs
Every batch. Every time.
cGMP & ISO 5
Benchmarks
Built for labs. Grounded in protocol.
TrustLoop™
Partnership
We test and we reward.
Zero Risk
Protocol™
Money back guaruntee.
Complete Custody
Never dropshipped.
MATCHED
COAs
Every batch.
Every time.
cGMP & ISO 5
Benchmarks
Grounded in protocol.
CJC-1295 DAC is a synthetic analogue of Growth Hormone Releasing Hormone (GHRH), modified with a Drug Affinity Complex (DAC) technology that significantly extends its half-life through covalent binding to circulating albumin. It has been the subject of substantial preclinical and clinical research, making it one of the most studied growth hormone secretagogues available to Canadian researchers today.
Researchers have investigated CJC-1295 DAC across a broad range of in vitro and in vivo models, with published studies exploring its role in stimulating pulsatile growth hormone secretion from anterior pituitary somatotroph cells. Clinical research has examined its interactions with the IGF-1 axis, with studies demonstrating sustained elevation of both growth hormone and insulin-like growth factor 1 (IGF-1) levels in human subjects. The DAC modification is of particular interest to researchers studying pharmacokinetic profiles, as it extends the effective half-life of GHRH analogues from minutes to approximately 6-8 days, enabling researchers to study prolonged GH secretagogue activity in their models.
CJC-1295 DAC is frequently selected by Canadian researchers studying growth hormone secretion pathways, pituitary function, and IGF-1 axis modulation, and is commonly referenced alongside Ipamorelin in multi-compound research protocols targeting complementary GH secretagogue mechanisms.
Ambros Labs supplies CJC-1295 DAC to qualified researchers across Canada from our Canadian inventory. Every batch is independently tested by a third-party Canadian laboratory using HPLC and mass spectrometry, with verifiable Certificates of Analysis available for every batch. All orders ship same-day from Canada with full chain of custody documentation.
For research use only. Not for human or veterinary use. For use by qualified researchers in appropriate laboratory settings only.
CAS Number: 863288-34-0
Molecular Weight (g/moL): 3649.3
Molecular Formula: C165H271N47O46
Sequence: Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-NH2 (DAC conjugated at Lys28)
Format: White Lyophilized Powder
Purity: Exceeds 99% HPLC
